Join the club for FREE to access the whole archive and other member benefits.

Jim Mellon

British entrepreneur, author and philanthropist with interests across a number of industries

Jim began his investment career in Asia and then moved to the US and worked for two fund management companies, GT Management and Thornton & Co. During this time he gained valuable insights into the companies and economies which would drive global growth over the following decades. He established his own business in 1991, which today persists as Charlemagne Capital and was recently acquired by Fiera Capital. He still controls Regent Pacific Group, a Hong Kong-listed company.

Through his private investment company, the Burnbrae Group, he has substantial real estate investments in Germany and in the Isle of Man, as well as shareholdings in private and public companies in sectors such as banking, commodities, leisure and healthcare.

Jim’s investment philosophy, which has led him to be recognised as one of the most successful investors of his generation, is underpinned by his ability to identify so-called “money-fountains” – market trends which will lead to step changes and the resulting investment opportunities.

Visit website: https://www.juvenescence-book.com/about-the-authors/

 jimmellonsbooks

 jim-mellon-1541a8206

 JimMellonBooks

See also

Juvenescence

Developing therapies against different aging related diseases.

Details last updated 24-Jun-2019

Jim Mellon News

Summary of Jim Mellon presentation at Longevity Med Summit

Summary of Jim Mellon presentation at Longevity Med Summit

Live Forever Club - 19-May-2023

Urges individuals with resources and a desire to contribute positively to humanity to invest in the longevity industry

SIRT6 variant plays a major role in preventing the aging process

SIRT6 variant plays a major role in preventing the aging process

Longevity Technology - 17-Aug-2021

Novel gene therapies to prevent the accelerated aging process

FDA approved LyGenesis' phase 2a trials on liver failure patients

FDA approved LyGenesis' phase 2a trials on liver failure patients

Longevity Technology - 30-Dec-2020

Raised $11M funding which goes into trials and developing functional organs

Donations being triple matched for SENS end-of-year fundraiser

Donations being triple matched for SENS end-of-year fundraiser

SENS Research Foundation - 01-Dec-2020

I've just donated to help #UnlockLongevity - these are the experts and they need funding!

Big investors join First Longevity funding round

Big investors join First Longevity funding round

Longevity Technology - 16-Oct-2020

Key investors raise funding to support longevity sector


Display all news

Jim Mellon is also referenced in the following:

Investing in the Future of Longevity – the Ketone Chapter

10-May-2022

Juvenescence webinar about the latest research and developments on future of longevity investment

Longevity Med Summit

04-May-2023 to 05-May-2023

Annual gathering of the entire longevity ecosystem to tackle the aging problem

Longevity Summit Dublin 2022

18-Sep-2022 to 20-Sep-2022

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

Longevity Summit Dublin 2023

17-Aug-2023 to 20-Aug-2023
Club discount available - click here

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

Transvision Madrid 2021

08-Oct-2021 to 10-Oct-2021

World congress discussing on futurist concepts like longevity extension, artificial intelligence, human enhancement and other technologies with first humanoid robot speaker, Sophia, organized by HumanityPlus.

Jim Mellon Creations

Juvenescence: Investing in the Age of Longevity

Amazon

The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies